StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Somil Mehta, Sharekhan

BUYMax Healthcare Institute Limited
Max Healthcare Institute share price target & all analyst calls

bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))1 Jul 2026via ET Now

Entry₹1,131.9Inferred
Target₹1,220
Total upside +7.78% (call closed)
Stop loss₹1,070-5.47% risk
At expiry₹1,090.814 Jul 2026, 3:30 pm
Expired-3.63%
Follow Somil Mehta for new calls(21% target hit, 253 closed calls)Get alertsWatch MAXHEALTH for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Jul 2026
3 supporting1 neutral0 opposing
Supports the BUY call (3)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Jul · 1w ago

Max Healthcare Institute Ltd provided an update on acquiring an equity stake in Yerawada Properties Private Limited and plans to establish a new super speciality hospital in Pune.

BSE · Company Update·30 Jun · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·22 Jun · 3w ago

Neutral / worth noting (1)

Max Healthcare Institute Limited's subsidiary, Kalinga Hospital Ltd., is involved in ongoing litigation. An interlocutory petition has been filed requesting a stay on a postal ballot notice related to

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·8 Jul · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Max Healthcare Institute

All analyst calls on Max Healthcare Institute

More from Somil Mehta, Sharekhan

Every call and its outcome